查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1970816

全球脫髮治療產品市場－按產品類型、最終用戶、分銷管道、地區和競爭格局分類的行業規模、佔有率、趨勢、機會和預測（2021-2031年）

Hair Loss Treatment Product Market - Global Industry Size, Share, Trends, Opportunity and Forecast, By Product Type, By End User, By Distribution Channel, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球除毛療程產品市場預計將從 2025 年的 28.5 億美元成長到 2031 年的 46.6 億美元，複合年成長率為 8.54%。

該領域涵蓋多種旨在緩解脫髮症和促進毛囊再生的解決方案，包括外用製劑、口服藥物、低功率雷射治療設備和整裝儀容輔助器具。推動該行業發展的關鍵因素包括：全球人口老化導致男性型脫髮症（雄性脫毛症）風險增加；可支配收入的成長使人們能夠負擔得起特定的美容治療；以及人們對個人儀容儀表的日益重視。這些經濟和生物學因素創造了持續的需求，確保了穩定的收入來源，這與短暫的消費趨勢或短暫的時尚潮流截然不同。

市場概覽
預測期 2027-2031
市場規模：2025年 28.5億美元
市場規模：2031年 46.6億美元
複合年成長率：2026-2031年 8.54%
成長最快的細分市場 女士
最大的市場 北美洲

然而，不受監管的黑市診所的興起帶來了嚴峻挑戰，威脅著病人安全，並削弱了消費者對核准治療通訊協定的信任。這個問題使法規環境複雜化，並可能阻礙合法、經臨床檢驗的解決方案的推廣應用。儘管存在這些障礙，該領域仍在持續發展。根據國際毛髮修復外科學會（ISHRS）的數據，到2025年，每位會員醫師平均接診的患者數量將比2021年增加20%。這一成長表明，越來越多的患者正在積極尋求毛髮再生的專業治療。

市場促進因素

直接面對消費者 (DTC) 管道和遠端醫療平台的擴張，從根本上改變了市場進入，減少了與脫髮諮詢相關的社會污名，並簡化了處方箋配送流程。這些以數位化為先導的生態系統繞過了傳統的臨床障礙，提供符合現代人對便利性和隱私性偏好的私密、個人化治療方案。透過將非同步醫療諮詢與訂閱式產品配送相結合，它們成功地吸引了此前無法獲得標準皮膚科護理的年輕、精通科技的人群。這種結構性轉變體現在市場領導的財務成功上。例如，Hims & Hers Health, Inc. 在 2025 年 11 月發布的 2025 年第三季財報中揭露，其季度營收為 5.99 億美元，這主要得益於尋求個人化健康解決方案的線上用戶激增。

同時，新型藥物製劑和生物製藥，特別是Janus激酶 (JAK) 抑制劑的引入，為重度自體免疫脫髮症的治療帶來了新的希望。傳統的局部治療往往效果不穩定，而這些先進的生物療法則針對脫髮症等疾病的潛在免疫通路，展現出卓越的療效，並提高了患者的依從性和支付意願。為了支持這項臨床進展，太陽製藥工業公司在 2025 年 7 月發布的新聞稿中宣布，隨著 LEQSELVI 在美國上市，臨床試驗中 33% 的患者在 24 週時幾乎完全恢復了頭皮毛髮。這項創新治療方法滿足了重要的未滿足醫療需求。根據美國脫髮症) 預測，到 2025 年，美國將有約 70 萬人患有脫髮症，這代表著下一代療法的巨大市場潛力。

市場挑戰

不受監管的黑市診所的擴張對全球除毛治療產品市場的持續成長構成重大障礙。這些非法機構通常會僱用無證技師以低價進行精細的外科手術，往往導致嚴重的疤痕、感染疾病和外觀不自然等不良後果。此類不利事件會嚴重損害除毛療程的聲譽，削弱消費者對除毛治療有效性和安全性的信心。因此，整體患者可能會對治療產生恐懼，並猶豫是否選擇有資格的醫療專業人員或核准的治療產品。這可能會阻礙合法相關人員的市場滲透和收入成長。

近期行業數據顯示，無證診所普遍存在，凸顯了問題的嚴重性。國際毛髮修復外科學會（ISHRS）預測，到2025年，59%的會員醫師將報告其所在地區有活躍的黑市診所。如此高的氾濫程度迫使合法產業疲於應對聲譽損害，並將資源投入到糾正措施中，而非專注於市場擴張和創新。

市場趨勢

頭髮護理的「皮膚化」正在從根本上改變產品開發。製造商們正在重新設計洗髮精和精華液，優先考慮維持頭皮微生物群的平衡和屏障功能。這種方法與臉部護膚類似。這種模式轉移將頭皮視為皮膚的延伸，並融入了透明質酸、水楊酸和益生菌等活性成分。它超越了簡單的頭髮表面護理，從細胞層面改善毛囊健康。這種將日常整裝儀容提升至醫學水平的方法正在推動皮膚化妝品品牌實現顯著的收入成長。根據歐萊雅集團於2025年2月發布的《2024會計年度報告》，其皮膚化妝品部門（包括薇姿等頭皮護理品牌）的銷售額達到70億歐元，較去年同期成長9.8%。

同時，口服營養補充品市場正在發生決定性的轉變。這主要源自於消費者逐漸認知到自身整體健康狀況（尤其是壓力、荷爾蒙平衡和營養狀況）與頭髮活力之間的關聯。這一趨勢支撐著「由內而外滋養美麗」的概念，即從被動的藥物干預轉向預防性的日常營養保健療法，利用植物性適應原和標準化臨床維生素。該領域的商業性前景十分廣闊。根據聯合利華於2025年2月發布的“2024會計年度業績報告”，在Nutrafol等高階品牌的推動下，其美容與健康業務部門實現了6.5%的銷售額成長。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球脫髮治療產品市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品類型（洗髮精和護髮素、精華液、精油、其他）
    • 按最終用戶（男性、女性）
    • 分銷通路（線上、線下）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美脫髮治療產品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲脫髮治療產品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區脫髮治療產品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲脫髮治療產品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲脫髮治療產品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球脫髮治療產品市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • The Procter & Gamble Company
  • Loreal SA
  • Unilever Plc
  • Taisho Pharmaceutical Holdings Co., Ltd
  • Pierre Fabre SA
  • The Man Company
  • Net Distribution Services Private Limited
  • Guiltfree Industries Limited
  • Sebamed
  • L'Occitane

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 27994

The Global Hair Loss Treatment Product Market is projected to expand from USD 2.85 Billion in 2025 to USD 4.66 Billion by 2031, registering a CAGR of 8.54%. This sector encompasses a range of solutions, including topical formulations, oral medications, low-level laser therapy devices, and surgical aids designed to alleviate alopecia and encourage follicular regrowth. Key drivers fueling this industry include an aging global population increasingly prone to androgenetic alopecia, rising disposable incomes that facilitate access to elective aesthetic treatments, and heightened social awareness regarding personal grooming. These underlying economic and biological factors provide sustained demand and ensure reliable revenue streams, distinct from temporary consumer fads or fleeting style trends.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 2.85 Billion
Market Size 2031USD 4.66 Billion
CAGR 2026-20318.54%
Fastest Growing SegmentWomen
Largest MarketNorth America

However, the rise of unregulated black market clinics presents a serious challenge by endangering patient safety and diminishing consumer trust in approved therapeutic protocols. This issue complicates the regulatory environment and may hinder the adoption of legitimate, clinically validated solutions. Despite these obstacles, the sector continues to grow; according to the International Society of Hair Restoration Surgery, the average number of patients treated per member physician rose by 20% in 2025 compared to 2021. This increase indicates a broadening patient base that is actively seeking professional interventions for hair restoration.

Market Driver

The expansion of Direct-to-Consumer (DTC) channels and telemedicine platforms is fundamentally transforming market access by reducing the stigma associated with hair loss consultations and simplifying prescription delivery. These digital-first ecosystems enable consumers to bypass traditional clinical hurdles, offering discreet, personalized treatment plans that align with the modern preference for convenience and privacy. By combining asynchronous medical consultations with subscription-based product fulfillment, these platforms have successfully attracted a younger, tech-savvy demographic that previously fell outside standard dermatological care. This structural shift is reflected in the financial success of market leaders; for instance, Hims & Hers Health, Inc. reported in its November 2025 "Third Quarter 2025 Financial Results" that quarterly revenue reached $599 million, driven largely by a surge in online subscribers seeking personalized health solutions.

Simultaneously, the introduction of novel drug formulations and biologic treatments, particularly Janus kinase (JAK) inhibitors, is revitalizing the therapeutic landscape for severe autoimmune hair disorders. Unlike conventional topical solutions that often produce variable results, these advanced biologic therapies target the immune pathways underlying conditions like alopecia areata, offering superior efficacy that encourages higher patient adherence and willingness to pay. Validating this clinical progress, Sun Pharmaceutical Industries Limited announced in a July 2025 press release regarding the U.S. launch of LEQSELVI that clinical trials showed 33% of patients regained almost all their scalp hair by week 24. This innovation meets a critical unmet need; according to the National Alopecia Areata Foundation, alopecia areata affects approximately 700,000 people in the United States in 2025, representing a significant market for these next-generation therapeutics.

Market Challenge

The spread of unregulated black market clinics acts as a formidable barrier to the sustained expansion of the Global Hair Loss Treatment Product Market. These illicit operations often employ unlicensed technicians to perform delicate surgical procedures at reduced costs, frequently resulting in substandard outcomes such as severe scarring, infections, or unnatural aesthetics. Such adverse events generate significant negative publicity that severely erodes consumer trust in the efficacy and safety of hair restoration. Consequently, potential patients may develop a generalized fear of treatment, hesitating to engage with legitimate medical professionals or approved therapeutic products, thereby stalling broader market adoption and revenue growth for compliant stakeholders.

The magnitude of this issue is evidenced by recent industry data highlighting the widespread reach of these unauthorized entities. According to the International Society of Hair Restoration Surgery, 59% of member physicians reported the active presence of black market clinics operating within their local municipalities in 2025. This high prevalence forces the legitimate industry to combat reputational damage and divert resources toward corrective interventions rather than focusing purely on market expansion and innovation.

Market Trends

The "skinification" of hair care is fundamentally altering product development, as manufacturers reformulate shampoos and serums to prioritize scalp microbiome balance and barrier function, similar to facial skincare. This paradigm shift treats the scalp as an extension of the skin, integrating active ingredients such as hyaluronic acid, salicylic acid, and probiotics to address follicular health at the cellular level rather than merely treating the hair shaft. This medicalized approach to daily grooming is driving substantial revenue gains for dermocosmetic brands; according to L'Oreal S.A.'s "2024 Annual Results" from February 2025, the Dermatological Beauty division, which houses scalp-focused brands like Vichy Dercos, reported like-for-like sales growth of 9.8% to reach €7 billion.

Simultaneously, there is a decisive market shift toward holistic ingestible supplements, driven by consumers recognizing the link between internal systemic health-specifically stress, hormonal balance, and nutrition-and hair vitality. This trend validates the "beauty-from-within" concept, moving beyond reactive pharmaceutical interventions to preventative, daily nutraceutical regimens that utilize botanical adaptogens and standardized clinical vitamins. The commercial viability of this segment is robust; according to Unilever PLC's "Full Year 2024 Results" in February 2025, the Beauty & Wellbeing business group, driven by prestige brands like Nutrafol, delivered underlying sales growth of 6.5%.

Key Market Players

  • The Procter & Gamble Company
  • Loreal S.A.
  • Unilever Plc
  • Taisho Pharmaceutical Holdings Co., Ltd
  • Pierre Fabre S.A.
  • The Man Company
  • Net Distribution Services Private Limited
  • Guiltfree Industries Limited
  • Sebamed
  • L'Occitane

Report Scope

In this report, the Global Hair Loss Treatment Product Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Hair Loss Treatment Product Market, By Product Type

  • Shampoo & Conditioner
  • Serum
  • Oil
  • Others

Hair Loss Treatment Product Market, By End User

  • Men
  • Women

Hair Loss Treatment Product Market, By Distribution Channel

  • Online
  • Offline

Hair Loss Treatment Product Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Hair Loss Treatment Product Market.

Available Customizations:

Global Hair Loss Treatment Product Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Hair Loss Treatment Product Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Shampoo & Conditioner, Serum, Oil, Others)
    • 5.2.2. By End User (Men, Women)
    • 5.2.3. By Distribution Channel (Online, Offline)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Hair Loss Treatment Product Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By End User
    • 6.2.3. By Distribution Channel
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Hair Loss Treatment Product Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By End User
        • 6.3.1.2.3. By Distribution Channel
    • 6.3.2. Canada Hair Loss Treatment Product Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By End User
        • 6.3.2.2.3. By Distribution Channel
    • 6.3.3. Mexico Hair Loss Treatment Product Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By End User
        • 6.3.3.2.3. By Distribution Channel

7. Europe Hair Loss Treatment Product Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By End User
    • 7.2.3. By Distribution Channel
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Hair Loss Treatment Product Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By End User
        • 7.3.1.2.3. By Distribution Channel
    • 7.3.2. France Hair Loss Treatment Product Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By End User
        • 7.3.2.2.3. By Distribution Channel
    • 7.3.3. United Kingdom Hair Loss Treatment Product Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By End User
        • 7.3.3.2.3. By Distribution Channel
    • 7.3.4. Italy Hair Loss Treatment Product Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By End User
        • 7.3.4.2.3. By Distribution Channel
    • 7.3.5. Spain Hair Loss Treatment Product Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By End User
        • 7.3.5.2.3. By Distribution Channel

8. Asia Pacific Hair Loss Treatment Product Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By End User
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Hair Loss Treatment Product Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By End User
        • 8.3.1.2.3. By Distribution Channel
    • 8.3.2. India Hair Loss Treatment Product Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By End User
        • 8.3.2.2.3. By Distribution Channel
    • 8.3.3. Japan Hair Loss Treatment Product Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By End User
        • 8.3.3.2.3. By Distribution Channel
    • 8.3.4. South Korea Hair Loss Treatment Product Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By End User
        • 8.3.4.2.3. By Distribution Channel
    • 8.3.5. Australia Hair Loss Treatment Product Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By End User
        • 8.3.5.2.3. By Distribution Channel

9. Middle East & Africa Hair Loss Treatment Product Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By End User
    • 9.2.3. By Distribution Channel
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Hair Loss Treatment Product Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By End User
        • 9.3.1.2.3. By Distribution Channel
    • 9.3.2. UAE Hair Loss Treatment Product Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By End User
        • 9.3.2.2.3. By Distribution Channel
    • 9.3.3. South Africa Hair Loss Treatment Product Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By End User
        • 9.3.3.2.3. By Distribution Channel

10. South America Hair Loss Treatment Product Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By End User
    • 10.2.3. By Distribution Channel
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Hair Loss Treatment Product Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By End User
        • 10.3.1.2.3. By Distribution Channel
    • 10.3.2. Colombia Hair Loss Treatment Product Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By End User
        • 10.3.2.2.3. By Distribution Channel
    • 10.3.3. Argentina Hair Loss Treatment Product Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By End User
        • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Hair Loss Treatment Product Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. The Procter & Gamble Company
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Loreal S.A.
  • 15.3. Unilever Plc
  • 15.4. Taisho Pharmaceutical Holdings Co., Ltd
  • 15.5. Pierre Fabre S.A.
  • 15.6. The Man Company
  • 15.7. Net Distribution Services Private Limited
  • 15.8. Guiltfree Industries Limited
  • 15.9. Sebamed
  • 15.10. L'Occitane

16. Strategic Recommendations

17. About Us & Disclaimer